The ELIXIR Compute Platform ensures that European cloud, compute, storage and access services fulfil the requirements of and are available for the life-science research community. European regulation on health data processing is evolving, computing capacity in national clouds is increasing and international standards are improving interoperability between the compute environments.

Research Data Management (RDM) is crucial for implementing FAIR and Open Science principles. ELIXIR Platforms and Nodes have invested in RDM, resulting in valuable tools and resources. The RDM Community aims to bring together RDM professionals to coordinate ELIXIR's activities and develop its vision. The short-term objectives include creating a knowledge exchange forum, coordinating the RDM ecosystem, and focusing on RDM training and data brokering.

Single-cell omics has revolutionised the way life science research is conducted. However, the unprecedented opportunities offered by single-cell omics technologies are accompanied by data analysis challenges.

The ELIXIR Training Platform has developed a series of training best practices and guidelines, covering several aspects of training development and delivery. These practices are the building blocks of the ‘ELIXIR Training Toolkit’, a collection of resources available in the ELIXIR website.

The ELIXIR Interoperability Platform (EIP) KnowledgeHub is proposed as a systematic approach to collate and disseminate knowledge, working in close partnership with the FAIR Services Architecture Framework to support and provide a dissemination forum for the outputs generated from Task 1. 

Over the next two years, the ELIXIR Interoperability Platform (EIP) will build on the extensive interoperability capacity building that has taken place to date, and deliver a set of interoperability stories that showcase EIP flagship interoperability services ‘in action’, and provide practical advice and guidance on the production of FAIR data and data analyses.

The ELIXIR Rare Disease (RD) Community will continue to be committed to the International Rare Disease Research Consortium (IRDiRC) Vision for 2027: Enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention.

The main goal for the ELIXIR Federated Human Data (FHD) Community is to position the Federated EGA (FEGA) framework as the core infrastructure driver to support human data sharing for research use-cases from nationally, European Commission, and/or internationally funded human health data sharing projects.

Many countries in Europe have nascent personalised medicine programmes indicating a shift in human genomics from a predominantly research-driven activity to one funded through healthcare. This is evidenced by the declaration of many European countries to sequence and share transnationally at least 1 million genomes by 2022. As healthcare is subject to national laws, genetic data generated in this way is not likely to be shared as widely as research data.

This Metabolomics Community-led study focusses on the standardization of fluxomics workflows. The study is led by ELIXIR Greece and ELIXIR Spain and supported by EMBL-EBI and 11 other national ELIXIR Nodes, among which ELIXIR Belgium (Bart Ghesquire).